- Posted June 06, 2014
- Tweet This | Share on Facebook
Michigan, 43 states settle with GlaxoSmithKline
LANSING (AP) - A multinational drugmaker is paying Michigan, 43 other states and the District of Columbia $105 million to settle complaints that the company unlawfully marketed three drugs.
Michigan Attorney General Bill Schuette announced Wednesday that Michigan's share of the settlement is $2.6 million. The settlement resolves allegations that London-based GlaxoSmithKline illegally marketed Advair, Paxil and Wellbutrin for purposes that hadn't been approved by the Food and Drug Administration.
GSK is prohibited from disseminating information that describes any so-called off-label use.
The asthma drug Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressants.
Published: Fri, Jun 06, 2014
headlines Oakland County
- Whitmer signs gun violence prevention legislation
- Department of Attorney General conducts statewide warrant sweep, arrests 9
- Adoptive families across Michigan recognized during Adoption Day and Month
- Reproductive Health Act signed into law
- Case study: Documentary highlights history of courts in the Eastern District
headlines National
- This LA lawyer levels up legal protections in the video game industry
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Legal champions to receive Spirit of Excellence Award at 2026 ABA Midyear Meeting
- Fake Sullivan & Cromwell entities used by scammers should be dissolved, suit says
- Hackers gained access to ‘small number’ of attorney emails at Williams & Connolly, firm confirms
- Before joining Anderson Kill, judge was accused of rude behavior on bench, retaliatory threats in ethics case
